Oklahoma 2022 2022 Regular Session

Oklahoma Senate Bill SB1016 Introduced / Bill

Filed 01/21/2021

                     
 
 
Req. No. 1454 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 58th Legislature (2021) 
 
SENATE BILL 1016 	By: Dahm 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to the Catastrophic Health Emergency 
Powers Act; amending 63 O.S. 2011, Section 6104, 
which relates to definitions; adding additional 
provision to definition; and providing an effecti ve 
date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2011, Section 6104, is 
amended to read as follows: 
Section 6104. As used in the Catastrophic Health Emergency 
Powers Act: 
1.  “Bioterrorism” means the intentional use of any 
microorganism, virus, infectious substance, or biological product 
that may be engineered as a result of biotechnology, or any 
naturally occurring or bioengineered component of any such 
microorganism, virus, infectious substance, or biological product, 
to cause death, disease , or other biological malfunction in a human, 
an animal, a plant, or another living organism in order t o influence   
 
 
Req. No. 1454 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
the conduct of government or to intimidate or coerce a civilian 
population; 
2.  “Catastrophic health emergency ” means an occurrence of 
imminent threat of a n illness or health condition that: 
a. is believed to be caus ed by any of the following: 
(1) a nuclear attack, 
(2) bioterrorism, 
(3) a chemical attack, or 
(4) the appearance of a novel or previously 
controlled or eradicated infectious agent or 
biological toxin, and 
b. poses a high probability of any of the following 
harms: 
(1) a large number of deaths in the affect ed 
population, 
(2) a large number of serious or long -term 
disabilities in the affected population, or 
(3) widespread exposure to an infectious or toxic 
agent that poses a significant risk of 
substantial future harm to a large number o f 
people in the affect ed population, or 
(4) overloading of hospitals, emergency rooms and 
medical facilities beyond their cap acity to serve 
the affected population;   
 
 
Req. No. 1454 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  “Chain of custody” means the methodology of tracking 
specimens for the purpose of maintaining control and acc ountability 
from initial collection to final disposition of the specimens and 
providing for accountability at each stage of collecting, handling , 
testing, storing, and transporting the specimens and reporti ng test 
results; 
4.  “Contaminated waste” means: 
a. “biological waste”, which includes blood and blood 
products, excretions, exudates, secretions, suctionin g 
and other body fluids, and waste mat erials saturated 
with blood or body fluids, 
b. “cultures and stocks”, which includes etiologic agents 
and associated biologicals, including specimen 
cultures and dishes and devices used to transfer, 
inoculate, and mix cultures, wastes from production of 
biologicals and serums, and discarded live and 
attenuated vaccines, 
c. “pathological waste”, which includes biopsy materials 
and all human tissues, anatomical parts that emanate 
from surgery, obstetrical procedures, necr opsy or 
autopsy and laboratory procedu res, and animal 
carcasses exposed to pathogens in research and the 
bedding and other waste from such animals, bu t does   
 
 
Req. No. 1454 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
not include teeth or formaldehyde or other 
preservative agents, and 
d. “sharps”, which includes nee dles, intravenous (IV) 
tubing with needles attached, scalpel blades, lancets, 
breakable glass tubes , and syringes that have been 
removed from their or iginal sterile containers ; 
5.  “Health care facility ” means any nonfederal institution, 
building, or agency or portion thereof, whether public o r private or 
for profit or nonprofit, that is used, operated , or designed to 
provide health services, medical tr eatment, or nursing, 
rehabilitative, or preventive care to any person or persons.  This 
includes, but is not limited to:  ambulatory surgical fa cilities, 
hospitals, infirmaries, intermediate care facilities , kidney 
dialysis centers, long -term care facilities, mental health centers, 
outpatient facilities, public health centers, rehabilitation 
facilities, residential treatments facilities, skilled n ursing 
facilities, special care facilities, medical laboratori es, and adult 
day-care centers.  This also include s, but is not limited to, the 
following related property when used for or in connection with the 
foregoing:  laboratories; research facilities; pharmacies; laundry 
facilities; health personnel training and lodging facilities; 
patient, guest, and health per sonnel food service facilities; and 
offices and office buildings for persons engaged in health care 
professions or services;   
 
 
Req. No. 1454 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
6.  “Health care provider” means any person or entity who 
provides health care se rvices including, but not limited to, 
physicians, pharmacists, dentists, physician assistants, nurse 
practitioners, registered and other nurses, paramedics, emergency 
medical or laboratory techn icians, and ambulance and emergency 
medical workers; 
7.  “Infectious disease” means a disease caused by a living 
organism or other pathogen , including a fungus, bacillus, parasite, 
protozoan, or virus.  An infectious d isease may, or may not, be 
transmissible from person to person, animal to person, or insect to 
person; 
8.  “Isolation” means the physical separation a nd confinement of 
an individual or groups of individuals who are infected or 
reasonably believed to be inf ected with a transmissible or possibly 
transmissible disease from nonisolated individuals, to preven t or 
limit the transmission of the disease to noni solated individuals; 
9.  “Mental health support personnel ” means, but is not limited 
to, psychiatrists, ps ychologists, social workers , and volunteer 
crisis counseling groups; 
10.  “Protected health informat ion” means any information, 
whether oral, written, electronic, visual, or any other form, that 
relates to the past, present , or future physical or mental he alth 
status, condition, treatment, ser vice, products purchased , or 
provision of care of an individua l, and that reveals the identity of   
 
 
Req. No. 1454 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
the individual whose health care is the subject of the information, 
or where there is a reasonable basis to believe such information 
could be utilized either alone or with other information that is, or 
should reasonably be known to be, available to predictable 
recipients of such information to reveal the identity of that 
individual; 
11.  “Public health authority ” means the Oklahoma State 
Commissioner of Health; or local health department that acts 
principally to protect o r preserve the health of the public; or any 
person directly authorized to act on behalf of the Oklahoma State 
Commissioner of Health or local health departm ent; 
12.  “Public safety authority ” means the Commissioner of Public 
Safety; or any local government agency that acts principally to 
protect or preserve the public safety; or any person directly 
authorized to act on behalf of the Commissioner of Public Saf ety or 
local agency; 
13.  “Quarantine” means the physical separation and confinement 
of an individual or groups of individuals, who are or may have be en 
exposed to a transmissible or possibly transmissible disease and who 
do not show signs or symptoms of a transmissible disease, from 
nonquarantined individuals, to prevent or limit the transmission of 
the disease to nonquarantined individuals;   
 
 
Req. No. 1454 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
14.  “Specimens” means, but is not limited to, blood, sputum, 
urine, stool, other bodily fluids, wastes, tissues , and cultures 
necessary to perform requir ed tests; 
15.  “Tests” means, but is not limited to, any diagn ostic or 
investigative analyses necessary to preve nt the spread of disease or 
protect the health, safety , and welfare of the public; 
16.  “Transmissible disease” means an infectious disease that 
can be transmitted from person to person; and 
17.  “Trial court” means the district court for the area in 
which isolation or quarantine is to occur, a court designated by the 
Public Health Emergency Plan under the Cat astrophic Health Emergency 
Powers Act, or to the district court for the area in which a 
catastrophic health emergency has been declared. 
SECTION 2.  This act shall become effective Novem ber 1, 2021. 
 
58-1-1454 MR 1/21/2021 9:24:32 PM